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Abstract
Purpose The aim of the present study was to develop a
short, easy-to-use, and acceptable psychosocial screening
instrument specific for breast cancer patients.
Methods Before the start of adjuvant chemotherapy, 164
(98.8%) women completed the Psychosocial Distress
Questionnaire-Breast Cancer (PDQ-BC) as part of routine
care. The PDQ-BC consists of questions about psychological
risk factors (i.e., trait anxiety and (lack of) social support),
psychosocial problems (i.e., state anxiety and depressive
symptoms), social problems, physical problems, body image,
financial problems, sexual problems, clinical factors (type of
surgery, adjuvant treatment other than chemotherapy and
psychiatric morbidity), and demographic factors (marital
status, age, and age of children).
Results On average, patients indicated that they needed
5 min to complete the PDQ-BC. All subscales were
significantly correlated with each other, except the correla-
tions of social support with physical problems and body
image. Confirmatory factor analysis supported the internal
structure of the PDQ-BC (comparative fit index=0.95
(χ
2(24)=43.3), p=0.009; non-normed fit index=0.91; root
mean square error of approximation=0.073). The internal
consistency (Cronbach’s alphas) of the subscales trait
anxiety, state anxiety, depressive symptoms, body image,
social problems, and physical problems were 0.88, 0.85,
0.86, 0.79, 0.42, and 0.69, respectively.
Conclusion The PDQ-BCisaneasy-to-complete,acceptable,
non-burdensome, and short screening instrument for routine
use in breast cancer patient care. This instrument facilitates a
greater awareness of the concerns and needs for breast cancer
patients care during treatment with chemotherapy and the
follow-up. It is linked to a good referral system to guide
allocation to the different levels of psychosocial care
providers.
Keywords Oncology.Cancer.Psychosocial.Breast
cancer.Screening.Psychosocial problems
Introduction
Among women, breast cancer is the most common type of
malignancy worldwide. Every year, more than 1.2 million
patients are diagnosed with breast cancer [1]. In the
Netherlands, one in every nine women will be diagnosed
with breast cancer during her life [2]. The prevalence rate of
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of earlier detection and the use of better adjuvant treatments
[3]. Multimodality treatment regimens improve survival
outcome but also contribute to a prolonged period of
medicalinterventionswithconcurrentpsychosocialproblems.
Patients may experience a number of psychosocial problems
(i.e., a combination of psychological and social problems),
notably psychological problems (i.e., anxiety, depressive
symptoms) [4, 5], psychosexual functioning (i.e., impair-
ments in sexual functioning, decreased libido, and relational
problems) [5–7], body image [8, 9], physical functioning
(fatigue) [10, 11], social problems (i.e., household activities
and job) [12], and financial problems [13]. These psychoso-
cial problems are experienced by 10% to 50% of the breast
cancer patients shortly after diagnosis and medical treatment
[4, 14–16]. Concerning the psychological problems, different
studies reported prevalence rates ranging from 14% to 54%
for depression [15, 17] and prevalence rates for anxiety
ranging from 8.6% to 49% [5]. This variation in prevalence
reflects differences in screening instruments, assessment
times, definitions of anxiety and depression, and the stages
of disease [18].
Studies have shown that several factors are associated
with an increased risk for developing psychosocial problems,
e.g., trait anxiety. Women with high scores on trait anxiety
have the tendency to respond to situations perceived as
threateningwitha riseinanxietyintensity[19]. These women
scored low on quality of life (QoL) [20, 21] and high on
fatigue and depressive symptoms [22], irrespective of
diagnosis. Furthermore, lower levels of depressive symptoms
and a greater sense of well-being were reported when
patients experienced adequate social support, especially from
family and close friends [23]. This indicates that a lack of
social support could be a risk factor for depressive
symptoms.
After treatment, patients frequently report a loss of
sexual interest and sexual enjoyment [5]. These problems
may be directly caused by the side effects of adjuvant
therapies, especially chemotherapy [6] and hormonal
therapy [7]. Higher degree of impairment of body image
is reported in patients after mastectomy compared with
patients having had breast conserving therapy [8, 9],
although the impact of the type of surgery may be related
to the patient’s age [24].
Fatigueandpainarethemostcommonphysicalsideeffects
of treatment of breast cancer. Berger and Higginbottham [10]
found that greater levels of fatigue were associated with
reporting experiencing more symptoms. Moreover, breast
cancer survivors who received chemotherapy may be at
higher risk for severe fatigue, which has been associated
with depression, pain, and sleep disturbance [11]. Finally, the
first year after diagnosis, especially young women seem to
suffer from psychosocial problems. One of the explanations
is that younger women with breast cancer undergo more
aggressive treatment [13]. These well-documented side
effects can have devastating short- and long-term psychoso-
cial consequences for patients.
Psychosocial problems are thought to limit the daily
activities and influence the overall QoL of breast cancer
patients. It is essential that psychosocial problems in
patients are recognized at an early stage since early
intervention improves outcome [25–27]. This is the main
reason why it is very important to assess these problems
and to try to facilitate patients to improve QoL. Thus, good
oncological care needs to aim at preventing psychosocial
problems by timely detection and offering help when
needed. A screening instrument to reveal psychosocial
problems is, therefore, important.
Nowadays, screening for psychosocial problems in
cancer patients receives much attention. The Dutch National
Cancer Control Programme has stated as their goal to develop
a screening program for psychosocial problems in the Dutch
guidelines before the year 2010 [28]. Regarding follow-up in
oncology, the National Health Council strongly advocates
that psychosocial care should be a regular part of follow-up
[29]. To assess psychosocial problems, a number of
screening instruments exist [30, 31] of which most are
not validated in a Dutch cancer population or only assess
psychological problems (i.e., anxiety and depressive
symptoms). Two screening instruments have been used
and validated in the Netherlands: first, the Hospital
Anxiety and Depression Scale (HADS), which is a 14-
item scale inquiring into anxiety and depressive symptoms
during the previous week. This scale has shown to be
reliable and valid [32]. However, the HADS only assesses
two specific psychological factors, which is depression
and anxiety. Other relevant aspects have not been
incorporated in this screening instrument. Second, the
Distress Thermometer (DT) was developed by the
American National Comprehensive Cancer Network
[26]. It is a frequently used measure to evaluate emotional
distress (i.e., social, psychological, and spiritual/religious
aspects) in cancer patients. At this moment, it is the
instrument of choice in the Netherlands. On a visual
analog scale, called the thermometer, patients can indicate
their level of distress by indicating a number on a scale
from 0 (no distress)t o1 0( unbearable distress). Recently,
the DT is validated in a Dutch cancer population [33]. The
DT has acceptable levels of sensitivity and specificity
[34–36]. The DT performs best in relation to distress, but
modestly with regard to anxiety and depression [37].
However, the thermometer of the DT is generic and
cannot be used for specific referral to various levels of
psychosocial care providers, i.e., social worker, psycholo-
gist, or psychiatrist. Apart from the thermometer, the DT
contains a number of questions regarding physical, psycho-
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provided are only yes/no and do not explore the extent of
these problems. In addition, neither the HADS nor the DT
identifies risk factors for psychological problems. Moreover,
these instruments are not linked to a referral system based on
norm scores for referral to the various levels of psychosocial
care providers. Therefore, the project group “Verwijs-Wijzer”
of the St. Elisabeth Hospital in Tilburg (EZT), the
Netherlands, in collaboration with Tilburg University,
hasdevelopedthePsychosocialDistressQuestionnaire-Breast
Cancer (PDQ-BC). The aim of the project group was to
develop a screening instrument that is multi-dimensional and
assesses the most important psychosocial problems and risk
factors in breast cancer patients. Moreover, this screening
instrument aims to optimize the care providers’ conversation
with patients regarding all psychosocial aspects and to give
cut-off scores for referral to various levels of psychosocial
care providers. The project group consisted of experts in
psychosocial care, i.e., social worker, psychologist, psychia-
trist, oncology nurse, nurse practitioner, and a member of the
psychosocial care department of the Comprehensive Cancer
Centre South.
Based on the literature [4–16, 20–23], the PDQ-BC
consists of nine scales assessing psychological risk factors
(i.e., trait anxiety and (lack of) social support) and state
anxiety, depressive symptoms, social problems, physical
problems, body image, financial problems, and sexual
problems. Scores on the PDQ-BC are linked to a decision
tree for referral to the various levels of psychosocial care
providers.
The aim of this study was to develop a short, easy-to-use
psychosocial screening instrument specific for breast cancer
patients (PDQ-BC) and to examine the acceptability,
preliminary reliability, and validity of the PDQ-BC. In
addition, this study examined whether the referral advice
based on the PDQ-BC to the various psychosocial care
providers was justified.
Methods
Patients
The pilot study was done from December 2006 until
December 2009 at the Department of Medical Oncology
of EZT. All breast cancer patients at the outpatient clinic
scheduled for adjuvant chemotherapy without a history of a
psychiatric disorder were eligible for this study. Patients
with a psychiatric disorder often already have coaching by a
care provider for psychosocial problems. It was decided
that this group was excluded from this study. One hundred
and sixty-six women visited the nurse practitioner before
chemotherapy was started. One woman was not eligible for
participation in this study due to a known psychiatric
disease, and one patient was excluded because she found it
too difficult to complete the questionnaire. Therefore, 164
women completed the PDQ-BC. This study was approved
by the local ethics committee.
Questionnaire
The PDQ-BC consists of nine subscales assessed by 35
questions, of which 31 were selected from existing and
valid questionnaires: Center of Epidemiologic Studies
Depression Scale (CES-D) [38], World Health Organization
Quality of Life instrument (WHOQOL-100) [39], European
Organization for Research and Treatment of Cancer Quality
of Life Questionnaire—Breast (EORTC QLQ BR-23) [40],
and the State Trait Anxiety Inventory (STAI) [19].
The scales trait anxiety (10 questions), depressive
symptoms (seven questions), physical problems (four
questions), body image (two questions), financial problems
(one question), and sexual problems (one question) were
developed by selecting items (highest factor loadings) from
the above-mentioned existing questionnaires using factor
analysis on data from a prospective follow-up study into the
role of personality factors on QoL in breast cancer patients
[20, 42, 43].
A distinction was made between trait anxiety (how one
generally feels; personality factor), a psychological risk
factor, and state anxiety (how one feels at the moment), a
psychological problem. Therefore, we needed questions
assessing trait anxiety and questions assessing state anxiety,
thereby increasing the number of questions that assess
anxiety. These questions were adapted from the STAI [19].
The questions concerning depressive symptoms were
adapted from the CES-D. The CES-D consists of a 20-item
self-report scale, assessing the presence and degree of
depressive symptoms [38]. The reliability and criterion
validity appear to be good for the Dutch population. The
questions on physical, financial, and sexual problems are
derived from the Dutch version of the WHOQOL-100 [39].
The questions on body image were adapted from the
EORTC QLQ BR-23, a reliable and valid supplementary
measure of the QOL in breast cancer patients [40, 41].
With regard to state anxiety, an existing and already
shortened instrument was used (STAI short form). This
reduction from 20 to six questions has been done and
validated by others [40, 44, 45]. This shortened instrument
has good psychometric properties. It is preferable to use
validated scales; therefore, we made no changes to this
existing short version.
The only question concerning social support was judged
important by the project group for referral to the social
worker because social support has shown to be a risk factor.
This question was developed by the group and is a
Support Care Cancer (2011) 19:1485–1493 1487combination of two existing questions into social support
from the WHOQOL. Because the two questions made a
distinction between friends and family and we did not think
that this distinction was important for screening, we made a
more generic question, leaving out the specific referral to
family and friends. Questions about social problems were
judged by the project group as relevant for determining
whether or not patients should be referred to a social
worker. These questions were developed by the project
group because no existing questionnaires assessed these
topics.
A question on financial problems was added by the
project group based on clinical experience of the social
worker that problems in this area may increase other
psychosocial problems. We have chosen to assess this issue
with a question from the WHOQOL that has shown to be a
good question in psychometric terms.
Clinical practice has shown that discussing sexuality was
perceived not relevant soon after diagnosis and in this stage
of adjuvant treatment. At this stage of treatment, patients
sometimes get irritated when health professionals discuss
sexual issues. Therefore, again, we have chosen one generic
sexuality question from the WHOQOL to address the
sexuality issue.
Thus, the PDQ-BC consists of nine subscales assessed
by 35 questions, with items addressing trait anxiety (10
questions, e.g., “I worry too much over something that
really doesn’t matter”), state anxiety (six questions, e.g., “I
feel calm”), depressive symptoms (seven questions, e.g., “I
feel depressed”), social problems (three questions, e.g.,
“There are practical problems with regard to my family as a
result of the disease and treatment”), social support (one
question, “I receive enough support from people around
me”), physical problems (four questions, e.g., “Ia m
satisfied with the energy that I have”), body image (two
questions, e.g., “I find it difficult to see myself naked”),
financial problems (one question, “I worry about money”),
and sexual problems (one question, “I have problems with
my sexual life”). The questions from the various existing
measures were formulated differently. Some questions were
formulated with I, and other with you; and other questions
were statements. Questions were reformulated in order to
get a uniform format. We have chosen to let all questions
start with I, because when we asked patients, they found
this a more pleasant way of posing the questions. We also
wanted a uniform response scale for the entire PDQ-BC to
make it easier to complete the measure. Therefore, the
response options for all questions are now ranging from 1
(not at all)t o4( very much).
In addition to the PDQ-BC, a number of questions
concerned demographic (marital status, age, and age of
children) and clinical factors (type of surgery, adjuvant
treatment other than chemotherapy, and pre-treatment
psychiatric morbidity). The questions on demographic
factors and trait anxiety only have to be completed at
baseline.
Procedure
All women who were eligible for participation were asked
by the nurse practitioner to answer the questions of the
PDQ-BC at their own home.
During the visit with the nurse practitioner, the scores
were calculated and accompanied by an advice regarding
the need for additional psychosocial care. This advice was
b a s e do np a t i e n t s ’ scores that were compared with
predetermined cut-off values. Possible outcomes of the
instrument were as follows: no referral, referral to a medical
social worker, referral to a psychologist, or referral to a
psychiatrist. An advice concerning a referral for psychoso-
cial counseling was discussed with the patient by the nurse
practitioner. If needed and after approval by the patient, the
patient was seen by one of the psychosocial care providers,
depending on the advice that originated from the scores on
the various parts of the screening instrument. In case
patients were referred to a psychosocial care provider, this
care provider was asked to indicate whether the referral was
appropriate. The cut-off scores for trait anxiety, state
anxiety, and depressive symptoms were derived for the
cut-off scores of the original, longer questionnaires. The
cut-off scores for the questions taken from the WHOQOL
(financial, physical, and sexual problems) [39] and the
EORTC-BR23 (body image) [40, 41] were derived from the
norm scores. The cut-off scores for the remaining aspects
(social problems and social support) were determined
during discussions within the project group. These cut-off
scores were subsequently tested with 10 patients to see
whether these scores resulted in a correct referral. In
addition, the project group also decided which combination
of scores above the cut-off scores let to a referral to social
work, psychology, or psychiatry. For instance, a score
slightly above the cut-off value on state anxiety (or
depressive symptoms) results in an advice for referral to
social work, whereas a combination of scores above the
cut-off values for both trait anxiety and state anxiety (or
depressive symptoms) resulted in an advice to visit a
psychologist. When a patient has extreme high scores on
trait anxiety or depressive symptoms, she is referred to
psychiatry.
Statistical procedure
Correlations were calculated between the subscales. For
each of the six scales of the PDQ-BC that consists of more
than one item, an exploratory factor analysis (method PCA)
was performed to examine whether each scale constitutes
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conducted to test whether the a priori structure of the
PDQ-BC is suited to a population with breast cancer
patients. The hypothesized model is presented in Fig. 1.
Goodness of fit was verified by the following fit indices:
the comparative fit index (CFI), the non-normed fit index
(NNFI), and the root mean square error of approximation
(RMSEA). The models have a satisfactory to good fit when
CFI and NNFI is at least 0.90 and RMSEA is 0.06 or
smaller [46]. Internal consistency was examined with
Cronbach’s alpha in the total population. Depending on
the number of questions in a (sub)scale, Cronbach’s alpha
should be at least 0.70 in case of four items or more [47].
Statistical Package for the Social Sciences (SPSS) 17.0 was
used for all calculations, except for the CFA; these data
were processed by AMOS.
Results
Patient and clinical characteristics of the participants are
shown in Table 1.
Internal structure
Correlations between the subscales are shown in Table 2.
All correlations were statistically significant, except the
correlations of social support with physical problems and
body image are not statistically significant. The subscales
trait anxiety, state anxiety, and depressive symptoms have
the highest correlations with each other (r’s between 0.70
and 0.80).
In general, the results of the principle components
analyses supported the one factor structure of each scale.
With the exception of the scale trait anxiety, which had two
factors (one method factor consisting of all recoded items),
all scales showed to consist of one factor using the
Eigenvalue >1 criterion, a criterion known to quickly
overestimate the number of factors. The structure of the
PDQ-BC was examined with confirmatory factor analysis.
The model without allowing for any correlated error terms
had a CFI of 0.87, a NNFI of 0.821, and a RMSEA of
0.116 (χ
2(27)=82.19) To reach a better fit, the model
required two correlations of two error terms (social
problems with financial problems and social problems with
physical problems) to reach a CFI of 0.93 (χ
2(25)=54.3,
p=0.001; NNFI=0.88; RMSEA=0.088). This fit further is
improved by adding another correlation between two error
terms (body image with problems with sexual life) to reach
a CFI of 0.95 (χ
2(24)=43.3, p=0.009; NNFI=0.91;
RMSEA=0.073).
Reliability
The Cronbach’s alphas of the subscales trait anxiety, state
anxiety, depressive symptoms, body image, social prob-
lems, and physical problems were 0.88, 0.85, 0.86, 0.79,
0.42, and 0.69, respectively.
Referral
Figure 2 shows the percentage of patients receiving a
referral advice. The scores of 77 patients (47%) indicated a
referral for psychosocial counseling (i.e., 29 to medical
social work and 48 to medical psychology). Of the latter
group, five patients already had psychosocial therapy in a
mental care setting outside the hospital. Twenty-nine
1 e7 Financial problems
e6 Physical problems
e5 Social problems
e4  Body image
e3 Depressive sympt
e2 State anxiety
e1 Trait anxiety
e8 Sexual problems
e9 Social support
Psychosocial
problems
1
1
1
1
1
1
1
1
1
Fig. 1 The hypothesized model
Table 1 Demographic and clinical characteristics of the participants
(N=164)
Characteristics
Age (mean ± SD) 50.3±8.9 (range 29–69)
Living with partner (yes/no) 138 (84.1)/26 (15.9)
Kids at home (yes/no) 85 (51.8)/79 (48.2)
Previously diagnosed with
breast cancer (yes/no)
6 (3.7)/158 (96.3)
Previous psychosocial
treatment (yes/no)
33 (20.1)/131 (79.9)
Type of surgery
BCT 47 (28.7)
MTC 116 (70.7)
No surgical treatment
(due to neoadjuvant chemotherapy)
1 (0.6)
Axillary dissection (yes/no) 113 (68.9)/51 (31.1)
Percentages are provided in brackets, except for age
SD standard deviation, BCT breast conserving therapy, MTC mastectomy
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five to a medical social worker, 19 to a medical
psychologist, and five to a professional outside the hospital.
Two patients with a referral advice to medical psychology
preferred medical social work. Two patients with a referral
to a psychologist preferred medical social work. Also, two
patients with a referral for medical psychologist were
referred to a psychiatrist before they had any contact with
a psychologist. Thus, of all participants, 14.6% was actually
referred for psychosocial counseling within the hospital.
Forty-eight (29.3%) with an advice for referral did not want
to be referred because they have not (yet) experienced the
need. Based on the discussions in the multidisciplinary
meeting between health care professionals, it was conclud-
ed that all referrals based on the PDQ-BC were correctly
made.
Acceptability of the PDQ-BC
One hundred and sixty-four patients completed the PDQ-BC.
Onlyone patient was unabletofillinthe screening instrument
due to limited mental capacities. On average, patients
indicated that they needed the 5-min range to complete the
PDQ-BC.
Patients indicated that the PDQ-BC was easy to complete
and the questions were perceived as relevant. They did not
Table 2 Correlations between the subscales of the PDQ-BC
TAtot SAtot DEtot SOtot PHYtot BOtot Support Financ
SAtot 0.72
DEtot 0.72 0.79
SOtot 0.29 0.30 0.41
PHYtot 0.42 0.45 0.49 0.41
BOtot 0.28 0.39 0.40 0.27 0.32
Support −0.28 −0.20 −0.16 −0.20 −0.07 −0.04
Financ 0.20 0.20 0.21 0.34 0.28 0.24 −0.08
Sex 0.35 0.26 0.32 0.35 0.19 0.30 −0.29 0.14
All correlations are significant, except that the correlations of Support with PHYtot and BOtot are not significant
TAtot subscale score trait anxiety, SAtot subscale score state anxiety, DEtot subscale score depressive symptoms, SOtot subscale score social
problems, PHYtot subscale physical problems, BOtot subscale score body image, Financ question concerning financial problems, Sex problems
with sexual life
 29 (17.7%)
accepted
this referral
77 (47%)
received an 
indication for 
psychosocial
counseling
 N=164
(98.8%)
29 MSW
(17.7%)
48 Med.
Psych
(29.3%)
5 MSW
19 Med.
Psych
3
7
22
2
5 refer on their 
own initiative
19
Med.Psych 2
17
17 Med.
Psych
2
Psychiatry
5 MSW
5 outside
hospital
Abbreviations:MSW=medical social work, Med.Psych=medical psychology
Fig. 2 The percentage of patients receiving a referral advice. MSW medical social work, Med.Psych psychology
1490 Support Care Cancer (2011) 19:1485–1493find it burdensome to complete the instrument, but found it
normal that these topics were discussed.
Discussion
The aim of this study was to develop a short, easy-to-use
psychosocial screening instrument specific for breast cancer
patients (PDQ-BC) and to examine the acceptability,
preliminary reliability, and validity of the PDQ-BC. In
addition, this study examined whether the referral advice
based on the PDQ-BC to the various psychosocial care
providers was justified.
Apart from these primary goals, there are several
benefits to develop a short and comprehensive, yet easy,
screening tool. First, about 10% to 50% of the women
with breast cancer suffer from psychosocial problems [4,
14–16]. The recent national guidelines state that psycho-
social care for cancer patients is obligatory and screening
measures should be implemented as part of the regular
care of breast cancer patients. As such, patients with
extended psychosocial problems can be identified and
professional psychosocial support can be offered. Secondly, a
brief questionnaire will be easy to incorporate into the regular
care because it takes little time to complete and to score the
results. Thus, a short screening tool can be completed several
times during treatment and during the follow-up program
withoutadditionalburdentopatientsandhealthprofessionals,
making implementation more probable.
Patients indicated that the PDQ-BC was easy to complete
and the questions were perceived as relevant. They did not
find it burdensome to complete the instrument. Only one
patient was unable to complete the screening instrument due
to limited mental capacities.
The nurse practitioner experienced that the PDQ-BC was
a good tool to systematically discuss a range of relevant
psychosocial problems. In this way, no problem areas were
neglected, and the nurse practitioner could spend attention
solely on those areas in which patients experienced problem
(s), which makes the discussion of these problems more
patient-tailored and, thus, more efficient. The instrument
facilitates a greater awareness of the concerns and needs for
breast cancer patients during treatment and regular follow-up.
Based on this experience, our findings underline the
acceptability and usefulness of the PDQ-BC in clinical
practice.
The PDQ-BC appears to have a good internal consistency.
According to Cohen [47], internal consistency of a scale is
considered good when it is above 0.70. Following this, the
internal consistency of the most subscales was good.
However, the subscale social problems had a much lower
Cronbach’s alpha. There are two probable reasons why the
alpha of the scale social problem is low. First, all scales with
less than four questions will have an instable and often too
low alpha. This is caused by the way an alpha is calculated.
Second, the low alpha for social problems may be caused by
the fact that each item was designed to tap into a different
aspect of social problems (i.e., practical problems concerning
family, practical problems with regard to work, and my
medical situation/treatment has impaired me in my social
functioning), which makes a high alpha less likely. This
provides a broad picture of patients’ social problems. In
addition, structural equation modeling showed that the
structure of the PDQ-BC had a good fit.
The PDQ-BC assesses psychological risk factors (trait
anxiety and lack of social support) and a range of problems
in breast cancer patients in the adjuvant setting (social
problems, physical problems, financial problems, body
image, sexual problems, and demographic information).
Forty-seven percent of patients were indicated for counseling.
This prevalence of psychosocial problems was comparable
with that reported in previous studies [4, 14–16]. In line with
previous studies, we also found that not all patients with an
increased level of these problems agreed to the suggested
referral. This study showed similar rates of declination as
compared with other studies [33].
Another screening instrument used in the Netherlands is
the DT. This measure and the PDQ-BC are comparable
concerning the percentage of patients that scored above the
cut-off score. There are also several differences between
both measures. One difference is that the PDQ-BC is
tailored for breast cancer patients, thereby not including
problems that are irrelevant for patients, such as difficulty
with speaking as a physical dysfunction. The cut-off scores
of the PDQ-BC concern specific aspects. Thus, the PDQ-
BC provides cut-off scores for all nine scales. Moreover,
the PDQ-BC has a differentiated outcome measure and
not dichotomous (yes/no), which assesses the extent to
which patients experience problems instead of a more
undifferentiated yes/no response. Based on this information,
the PDQ-BC results in a clear cut-off value for referral to the
various specific psychosocial care providers. From the 164
patients, 77 patients (47%) have an indication for counseling,
of whom 24 patients (31%) were actually referred: five
patients to the medical social worker and 19 to the
psychologist. Besides the care from the treating physician
and nurse practitioner, most of the other patients refused
referral except for five patients who preferred care from a
social care provider outside the hospital.
More patients were referred to a psychologist than a
social worker. An explanation could be that the PDQ-BC
assesses risk factors for psychosocial problems. That is, an
increased level of trait anxiety in combination with an
increased level of state anxiety or depressive symptoms on
the PDQ-BC is an indication for referral to a medical
psychologist. Patients high on trait anxiety have a tendency
Support Care Cancer (2011) 19:1485–1493 1491to respond with a rise in anxiety in stressful situations and
are at risk of experiencing, for instance, more fatigue [20]
and a low QoL [20, 39]. These patients may benefit from
psychotherapy [26, 48]. According to the health profes-
sionals, patients were correctly referred to medical social
work or medical psychology.
It is conceivable that during the phase of treatment, the
need for psychosocial support changes and as a result the
rate of patients who seek referral also changes. Therefore, it
is necessary to examine the referral information for
psychosocial care across time. We do not yet have
information on test–retest reliability and sensitivity to
change. Future studies will need to focus on examining
these features of the PDQ-BC as well as the sensitivity and
specificity.
In conclusion, the PDQ-BC is developed with special
attention to specific issues relevant for breast cancer
patients receiving adjuvant chemotherapy. It seems to be a
useful instrument for selecting and referring those breast
cancer patients who experience psychosocial problems and
also seek to be referred. Patients who refrain from
psychosocial care are monitored. The PDQ-BC is an easy-
to-complete questionnaire and its psychometric properties
are promising.
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